Jeffrey L. Wade

2010

In 2010, Jeffrey L. Wade earned a total compensation of $1.1M as Executive Vice President, Corporate Development and Chief Financial Officer at Lexicon Pharmaceuticals, a 26% increase compared to previous year.

Compensation breakdown

Bonus$35,000
Option Awards$670,268
Salary$374,375
Stock Awards$60,040
Other$6,668
Total$1,146,351

Wade received $670.3K in option awards, accounting for 58% of the total pay in 2010.

Wade also received $35K in bonus, $374.4K in salary, $60K in stock awards and $6.7K in other compensation.

Rankings

In 2010, Jeffrey L. Wade's compensation ranked 4,820th out of 10,439 executives tracked by ExecPay. In other words, Wade earned more than 53.8% of executives.

ClassificationRankingPercentile
All
4,820
out of 10,439
54th
Division
Manufacturing
1,726
out of 3,838
55th
Major group
Chemicals And Allied Products
355
out of 926
62nd
Industry group
Drugs
205
out of 685
70th
Industry
Pharmaceutical Preparations
158
out of 481
67th
Source: SEC filing on March 25, 2013.

Wade's colleagues

We found seven more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2010.

2010

Arthur Sands

Lexicon Pharmaceuticals

Chief Executive Officer

2010

Brian Zambrowicz

Lexicon Pharmaceuticals

Chief Scientific Officer

2010

Alan Main

Lexicon Pharmaceuticals

Executive Vice President of Pharmaceutical Research

2010

Philip Brown

Lexicon Pharmaceuticals

Former Senior Vice President, Clinical Development

2010

James Tessmer

Lexicon Pharmaceuticals

Vice President, Finance and Accounting

2010

Steven Tragash

Lexicon Pharmaceuticals

Former Senior Vice President of Corporate Affairs

2010

Ajay Bansal

Lexicon Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like